IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $3,947,000 | +624.2% | 46,400 | +21.5% | 0.19% | +419.4% |
Q4 2018 | $545,000 | -31.5% | 38,194 | 0.0% | 0.04% | +5.9% |
Q3 2018 | $796,000 | -11.9% | 38,194 | 0.0% | 0.03% | -19.0% |
Q2 2018 | $904,000 | +46.8% | 38,194 | -9.5% | 0.04% | +35.5% |
Q1 2018 | $616,000 | -78.1% | 42,194 | -75.8% | 0.03% | -77.7% |
Q4 2017 | $2,817,000 | +32.4% | 174,294 | +14.6% | 0.14% | +33.7% |
Q3 2017 | $2,128,000 | +106.2% | 152,100 | +30.2% | 0.10% | +108.0% |
Q2 2017 | $1,032,000 | +42.1% | 116,834 | +4.2% | 0.05% | +16.3% |
Q1 2017 | $726,000 | -17.6% | 112,100 | -53.3% | 0.04% | -10.4% |
Q4 2016 | $881,000 | +13.2% | 239,809 | +0.0% | 0.05% | +26.3% |
Q3 2016 | $778,000 | +11.9% | 239,710 | -20.2% | 0.04% | -19.1% |
Q2 2016 | $695,000 | +190.8% | 300,210 | +212.7% | 0.05% | +213.3% |
Q1 2016 | $239,000 | -9.5% | 96,000 | +11.6% | 0.02% | -6.2% |
Q4 2015 | $264,000 | +371.4% | 86,000 | +164.6% | 0.02% | +433.3% |
Q3 2015 | $56,000 | -57.6% | 32,500 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $132,000 | – | 32,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |